揿针疗法联合鼓室内注射治疗突发性耳聋的疗效观察

Efficacy of press-needle therapy combined with intratympanic injection in treating patients with sudden hearing loss

  • 摘要:
    目的 探讨揿针疗法联合鼓室内注射对突发性耳聋(SHL)患者的疗效。
    方法 回顾性分析首都医科大学附属北京安贞医院南充医院2021年9月—2024年9月收治的157例SHL患者的临床资料。将患者按照治疗方法分为2组,均给予营养神经和地塞米松磷酸钠注射液治疗,其中常规组采取鼓室内注射治疗,联合组在上述基础上加用揿针疗法。采用倾向性匹配评分法排除性别、年龄、病程、患耳侧别、听力损失分型、合并症等基线资料混杂因素,最终2组各纳入54例患者。连续治疗10 d后,比较2组患者炎症因子白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、内耳血循环指标(小脑前下动脉管径、内听动脉管径)、纯音听阈值、中医证候积分以及不良反应发生情况(胃肠道不适、出血、一过性晕眩、短暂性耳痛等)。
    结果 2组治疗10 d后IL-6、TNF-α水平均较治疗前降低,小脑前下动脉管径和内听动脉管径均较治疗前增大,且联合组IL-6、TNF-α水平低于常规组,小脑前下动脉管径和内听动脉管径大于常规组,差异均有统计学意义(P<0.05)。2组治疗5、10 d后纯音听阈值均低于治疗前,治疗10 d后的纯音听阈值最低,且联合组治疗5、10 d后纯音听阈值均低于常规组,差异均有统计学意义(P<0.05)。2组治疗10 d后的听力减退、耳鸣、眩晕、心悸失眠症状的中医证候积分均较治疗前降低,且联合组上述症状的中医证候积分低于常规组,差异有统计学意义(P<0.05)。治疗期间,联合组不良反应总发生率为14.81%(8/54), 常规组为11.11%(6/54), 差异无统计学意义(P>0.05)。
    结论 揿针疗法联合鼓室内注射能够有效减轻患者炎症反应,改善内耳血循环和听力状况,缓解临床症状,且安全性较好。

     

    Abstract:
    Objective To investigate the efficacy of press-needle therapy combined with intratympanic injection in treating patients with sudden hearing loss (SHL).
    Methods A retrospective analysis was conducted on the clinical data of 157 SHL patients in the Nanchong Hospital of Beijing Anzhen Hospital Affiliated to Capital Medical University from September 2021 to September 2024. Patients were divided into two groups according to the treatment method. Both groups received nerve nutrition therapy and dexamethasone sodium phosphate injection. The conventional group underwent intratympanic injection, while the combined group received press-needle therapy on the basis of the aforementioned treatment. The propensity score matching method was used to exclude confounding factors in baseline data, including gender, age, disease duration, affected ear side, classification of hearing loss, and comorbidities. Finally, 54 patients were included in each group. After 10 consecutive days of treatment, the inflammatory factors interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), inner ear blood circulation indicators (diameter of the anterior inferior cerebellar artery, diameter of the internal auditory artery), pure tone audiometry thresholds, scores of traditional Chinese medicine syndromes, and the occurrence of adverse reactions (gastrointestinal discomfort, bleeding, transient dizziness, transient ear pain, etc.) were compared between the two groups.
    Results After 10 days of treatment, the levels of IL-6 and TNF-α in both groups were lower than those before treatment, and the diameters of the anterior inferior cerebellar arteryand the internal auditory artery were larger than those before treatment; moreover, the levels of IL-6 and TNF-α in the combined group were lower than those in the conventional group, and the diameters of the anterior inferior cerebellar artery and the internal auditory artery were larger than those in the conventional group; all the differences mentioned above were statistically significant (P < 0.05). After 5 and 10 days of treatment, the pure tone audiometry thresholds in both groups were lower than those before treatment in the same group, with the lowest thresholds observed after 10 days of treatment; furthermore, the pure tone audiometry thresholds in the combined group after 5 and 10 days of treatment were lower than those in the conventional group; all the differences mentioned above were statistically significant (P < 0.05). After 10 days of treatment, the traditional Chinese medicine syndrome scores for symptoms such as hearing loss, tinnitus, dizziness, palpitations, and insomnia in both groups were lower than those before treatment; moreover, the scores of traditional Chinese medicine syndromes for the aforementioned symptoms in the combined group were lower than those in the conventional group; all the differences mentioned above were statistically significant (P < 0.05). During the treatment period, the total incidence of adverse reactions was 14.81% (8/54) in the combined group and 11.11% (6/54) in the conventional group, with no significant between-group difference (P>0.05).
    Conclusion Press-needle therapy combined with intratympanic injection can effectively reduce inflammation, improve inner ear blood circulation and hearing status, alleviate clinical symptoms, and demonstrate good safety.

     

/

返回文章
返回